Resources

We asked our readers to give us feedback into how much they knew about GLP-1 Analogs and a broad cross-section replied. Take a look at 5 of the questions and how your colleagues answered…. It appears that most of you knew that a large amount of GLP-1 production is lost …

In order to increase compliance and improve efficacy, there is an experimental long acting exenatide once monthly injectable suspension in the pipeline. This long acting formulation is currently in phase-2 trial and has showed promising results in controlling A1C in type 2 diabetes patients….

The investigational drug Lyxumia® (lixisenatide), a once daily GLP-1 agonist, is making progress as a newer drug in this increasingly crowded class of drugs.  Data from four studies of the GetGoal Phase III clinical program was presented at the ADA sessions….

Adding Insulin to Metformin and Liraglutide: A New Sequence of Medication Therapy for Type-2 Diabetes Patients A new clinical study shows for the first time that the addition of long-acting insulin to the medication regimen of Metformin plus Victoza (liraglutide) allowed patients to reach an A1c goal of less-than-7% with …

Edited by Trisha Dunning AM, RN, MEd, PhD, CDE, FRCNA and Glenn Ward MBBS, BSc, DPhil (Oxon), FRACP, FRCPath Mrs. PJ was referred to the diabetes centre by a physician in the infectious diseases department of a large metropolitan hospital. Mrs. PJ is an 80-year-old woman who has had type …

This week we present PART 3 of our series on the Diagnosis and Management of Diabetic Eye Disease, focusing on cataracts and keratopathy….

  Does vitamin D really help to prevent type 2 diabetes?…

Initial studies of the artificial pancreas used only a partially automated system to monitor glucose levels and deliver appropriate doses of insulin.…

Weight loss surgery is an effective means of treatment for people with diabetes who are morbidly obese.…

Is working the night shift bad for you?…